Eine Plattform für die Wissenschaft: Bauingenieurwesen, Architektur und Urbanistik
Triple Negative Breast Cancer: Nanosolutions for a Big Challenge
Triple negative breast cancer (TNBC) is a particular immunopathological subtype of breast cancer that lacks expression of estrogen and progesterone receptors (ER/PR) and amplification of the human epidermal growth factor receptor 2 (HER2) gene. Characterized by aggressive and metastatic phenotypes and high rates of relapse, TNBC is the only breast cancer subgroup still lacking effective therapeutic options, thus presenting the worst prognosis. The development of targeted therapies, as well as early diagnosis methods, is vital to ensure an adequate and timely therapeutic intervention in patients with TNBC. This review intends to discuss potentially emerging approaches for the diagnosis and treatment of TNBC patients, with a special focus on nano‐based solutions that actively target these particular tumors.
Triple Negative Breast Cancer: Nanosolutions for a Big Challenge
Triple negative breast cancer (TNBC) is a particular immunopathological subtype of breast cancer that lacks expression of estrogen and progesterone receptors (ER/PR) and amplification of the human epidermal growth factor receptor 2 (HER2) gene. Characterized by aggressive and metastatic phenotypes and high rates of relapse, TNBC is the only breast cancer subgroup still lacking effective therapeutic options, thus presenting the worst prognosis. The development of targeted therapies, as well as early diagnosis methods, is vital to ensure an adequate and timely therapeutic intervention in patients with TNBC. This review intends to discuss potentially emerging approaches for the diagnosis and treatment of TNBC patients, with a special focus on nano‐based solutions that actively target these particular tumors.
Triple Negative Breast Cancer: Nanosolutions for a Big Challenge
Mendes, Tânia Filipa S. (Autor:in) / Kluskens, Leon D. (Autor:in) / Rodrigues, Lígia Raquel (Autor:in)
Advanced Science ; 2
01.11.2015
14 pages
Aufsatz (Zeitschrift)
Elektronische Ressource
Englisch
WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer
Wiley | 2021
|AKT1 Phosphorylates FDX1 to Promote Cuproptosis Resistance in Triple‐Negative Breast Cancer
Wiley | 2025
|THOC2 and THOC5 Regulate Stemness and Radioresistance in Triple‐Negative Breast Cancer
Wiley | 2021
|Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple‐Negative Breast Cancer
Wiley | 2024
|Autophagy Deficiency Induced by SAT1 Potentiates Tumor Progression in Triple‐Negative Breast Cancer
Wiley | 2024
|